Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Exxon Mobil
XOM
|
$267M |
| 2 |
Chevron
CVX
|
$202M |
| 3 |
Tesla
TSLA
|
$201M |
| 4 |
NVIDIA
NVDA
|
$182M |
| 5 |
Pfizer
PFE
|
$123M |
Top Sells
| 1 |
Apple
AAPL
|
$270M |
| 2 |
First Solar
FSLR
|
$147M |
| 3 |
Walmart
WMT
|
$138M |
| 4 |
Steel Dynamics
STLD
|
$123M |
| 5 |
Reliance Steel & Aluminium
RS
|
$117M |
Sector Composition
| 1 | Technology | 17.96% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.49% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Verrica Pharmaceuticals
VRCA
$48.3M
| $97.9K | ﹤0.01% |
1,697
| – | – |
|
3327
Compass Therapeutics
CMPX
$590M
| $96.8K | ﹤0.01% |
+30,450
| New | +$96.8K |
|
3328
Century Therapeutics
IPSC
$43.6M
| $96.4K | ﹤0.01% |
30,491
-8,962
| -23% | -$28.3K |
|
3329
Immunic
IMUX
$75.1M
| $96K | ﹤0.01% |
38,232
+10,358
| +37% | +$26K |
|
3330
BioAtla
BCAB
$31.5M
| $95.8K | ﹤0.01% |
31,938
-14,053
| -31% | -$42.2K |
|
3331
Byrna Technologies
BYRN
$445M
| $95.8K | ﹤0.01% |
19,123
| – | – |
|
3332
Lendway
LDWY
$10.1M
| $95.8K | ﹤0.01% |
12,704
| – | – |
|
3333
ThredUp
TDUP
$1.43B
| $94.8K | ﹤0.01% |
38,849
+12,684
| +48% | +$30.9K |
|
3334
CPS Technologies
CPSH
$48.8M
| $94K | ﹤0.01% |
33,581
-2
| -0% | -$6 |
|
3335
Gain Therapeutics
GANX
$63.3M
| $93.9K | ﹤0.01% |
20,962
+2,355
| +13% | +$10.6K |
|
|
APRN
3336
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $92.7K | ﹤0.01% |
+15,876
| New | +$92.7K |
|
3337
Fathom Holdings
FTHM
$55.4M
| $92.2K | ﹤0.01% |
+12,912
| New | +$92.2K |
|
3338
Medallion Financial
MFIN
$249M
| $90.6K | ﹤0.01% |
11,451
| – | – |
|
3339
908 Devices
MASS
$196M
| $89.9K | ﹤0.01% |
13,107
-29,410
| -69% | -$202K |
|
3340
Coffee Holding Co
JVA
$23.7M
| $89.1K | ﹤0.01% |
64,104
-26,234
| -29% | -$36.5K |
|
3341
Vicarious Surgical
RBOT
$33.9M
| $88.6K | ﹤0.01% |
+1,615
| New | +$88.6K |
|
3342
Franklin Wireless
FKWL
$48.4M
| $87.6K | ﹤0.01% |
23,495
| – | – |
|
|
ONCY
3343
Oncolytics Biotech
ONCY
$107M
| $87.1K | ﹤0.01% |
33,485
| – | – |
|
|
ZEV
3344
DELISTED
Lightning eMotors, Inc.
ZEV
| $86.3K | ﹤0.01% |
+23,978
| New | +$86.3K |
|
3345
Black Diamond Therapeutics
BDTX
$167M
| $86.3K | ﹤0.01% |
17,087
-8,833
| -34% | -$44.6K |
|
|
ORKA
3346
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
| $86.3K | ﹤0.01% |
3,542
| – | – |
|
3347
CorMedix
CRMD
$926M
| $85.6K | ﹤0.01% |
21,601
| – | – |
|
3348
PharmaCyte Biotech
PMCB
$6.46M
| $83.8K | ﹤0.01% |
29,303
| – | – |
|
|
DMTK
3349
DELISTED
DermTech, Inc. Common Stock
DMTK
| $83K | ﹤0.01% |
+31,932
| New | +$83K |
|
|
ADAP
3350
Adaptimmune Therapeutics
ADAP
$10.9M
| $82K | ﹤0.01% |
+88,580
| New | +$82K |
|